Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,429Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-329.5EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)20.9Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.4PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M43,059,773ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with VHT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VHTKen Fisher 2016-03-31 Sold Out $114.49 - $132.88
($121.69)
$ 126.094%Sold Out0
VHTKen Fisher 2015-12-31 Buy $123.27 - $134.76
($130.49)
$ 126.09-3%New holding1,808
VHTKen Fisher 2013-12-31 Buy $91.43 - $97.64
($95.51)
$ 126.0932%New holding3,028
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VHT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


VHT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Brown, ArthurDirector, Senior Officer 2016-11-08Buy25,000$0.2844817.86view
BACH, WENDYSenior Officer 2016-11-08Sell3,549$48.06161.69view
BACH, WENDYSenior Officer 2016-11-08Buy4,619$48.08161.58view
BACH, WENDYSenior Officer 2016-11-08Sell1,070$48.06161.69view
Miller, James MichaelSenior Officer 2016-11-08Buy5,000$4.32824.88view
Omni-Lite Industries Canada InIssuer 2016-11-08Buy2,300$1.657522.42view
PAMPLIN, Ann-Marie MichelleDeemed Insider - 6 Months before becoming Insider 2016-11-08Buy13,000$0.1396646.15view
Glazier, Patrick L.Director 2016-11-08Buy100,000$0.1489735.71view
Sutton, Brayden RobertDirector 2016-11-08Buy5,000$0.2844817.86view
Reilly, Robert BruceSenior Officer 2016-11-08Sell155,000$0.06209516.67view

Quarterly/Annual Reports about VHT:

    News about VHT:

    Articles On GuruFocus.com
    Baidu: A Great Opportunity for Long-Term Investors Dec 04 2016 
    Intel's Future Still Looks Bright Dec 04 2016 
    CBS Corp: Navigating the Media Challenges Well Dec 04 2016 
    How General Electric Is Re-Positioning Itself for Dividend Growth Dec 04 2016 
    Warren Buffett Shares His Thoughts About the Election Dec 04 2016 
    Weekly Top Insider Buys Highlight for the Week of Dec. 2 Dec 04 2016 
    Jokes, Analogies and Anecdotes in Warren Buffett’s Shareholder Letters Dec 04 2016 
    Low-Priced Retail Stocks Gurus Shopped for Ahead of Holiday Season Dec 02 2016 
    Barrick Repurchases $595 Million of Corporate Loan Dec 02 2016 
    23 Questions With Bakul Lalla Dec 02 2016 

    More From Other Websites
    Why Merck’s Immunology Business Matters Now Dec 05 2016
    [$$] Gearing Up for Growth in the Trump Era Dec 03 2016
    Recent R&D Developments from Merck You Won’t Want to Miss Dec 01 2016
    Major Product Developments for Pfizer Dec 01 2016
    Allergan’s News: Recent Acquisitions and Divestments Nov 29 2016
    The Pfizer-Medivation Deal, Completed in 3Q16 Nov 29 2016
    Pfizer’s Valuation Compared to Peers Nov 29 2016
    Where Does Eli Lilly’s Valuation Stand Next to Peers? Nov 22 2016
    The Positive Performance of the Healthcare Sector Nov 21 2016
    Can Trump's Presidency Heal Pharma Stocks? (XLV, VHT) Nov 14 2016
    Taking Stock of Trump’s Triumph Nov 10 2016
    How To Profit With ETFs Under A President Donald Trump Nov 10 2016
    This Contributed to Pfizer’s Growth in 3Q16 Nov 07 2016
    Pfizer’s 3Q16 Earnings: Revenue Stream Nov 07 2016
    The One Election-Proof Industry Nov 02 2016
    Merck & Co.’s Profitability in 3Q16 Nov 01 2016
    Obamacare: Will the Next US President Kill It or Cure It? Oct 31 2016
    Factors Impacting Merck & Co.’s Growth in 3Q16 Oct 28 2016
    Inside Opdivo, Bristol-Myers Squibb’s Oncology Drug Oct 26 2016
    Johnson & Johnson’s Valuation Cheat Sheet 3Q16 Oct 25 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)